| Style | Citing Format |
|---|---|
| MLA | Roshandel G, et al.. "Polypill for Prevention of Cardiovascular Diseases – Authors' Reply." The Lancet, vol. 395, no. 10222, 2020, pp. 414-415. |
| APA | Roshandel G, Kamangar F, Marshall T, Cheng KK, Hemming K, Malekzadeh R (2020). Polypill for Prevention of Cardiovascular Diseases – Authors' Reply. The Lancet, 395(10222), 414-415. |
| Chicago | Roshandel G, Kamangar F, Marshall T, Cheng KK, Hemming K, Malekzadeh R. "Polypill for Prevention of Cardiovascular Diseases – Authors' Reply." The Lancet 395, no. 10222 (2020): 414-415. |
| Harvard | Roshandel G et al. (2020) 'Polypill for Prevention of Cardiovascular Diseases – Authors' Reply', The Lancet, 395(10222), pp. 414-415. |
| Vancouver | Roshandel G, Kamangar F, Marshall T, Cheng KK, Hemming K, Malekzadeh R. Polypill for Prevention of Cardiovascular Diseases – Authors' Reply. The Lancet. 2020;395(10222):414-415. |
| BibTex | @article{ author = {Roshandel G and Kamangar F and Marshall T and Cheng KK and Hemming K and Malekzadeh R}, title = {Polypill for Prevention of Cardiovascular Diseases – Authors' Reply}, journal = {The Lancet}, volume = {395}, number = {10222}, pages = {414-415}, year = {2020} } |
| RIS | TY - JOUR AU - Roshandel G AU - Kamangar F AU - Marshall T AU - Cheng KK AU - Hemming K AU - Malekzadeh R TI - Polypill for Prevention of Cardiovascular Diseases – Authors' Reply JO - The Lancet VL - 395 IS - 10222 SP - 414 EP - 415 PY - 2020 ER - |